Both join from Viopas Partners
Deep Dive into global equities
Investors choose their ones to watch for this year
Vaccine breakthrough proves anything is possible
Innovation and adaptation key to companies' strength
Follows senior European hires this month
Diagnostics firms among 35-strong portfolio
Areas from emerging market growth to ESG and healthcare